InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,463.69
(
-0.10%
)
US TECH 100
19,166.40
(
-0.05%
)
Dow Jones
39,085.68
(
-0.07%
)
Brent Oil
84.04
(
-0.18%
)
Bitcoin
61,283.97
(
-0.85%
)
Post# of 18784
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

TwoPack

Send PM Follow Ignore
Followers 3
Posts 83
Boards Moderated 0
Alias Born 07/17/2014

TwoPack

Re: MinnieM post# 8559

Wednesday, 09/23/2015 4:03:52 PM

Wednesday, September 23, 2015 4:03:52 PM

Post# of 18784
Possibly UT Southwestern is not allowed to post such an estimation about ZoptEC, so they better removed the statement away from their site.
But it seems to me Zoptarelin-Doxorubicin could have worked fine for Southwestern patients while treating their patients during the study.

Thanks for the membermark
an GLTY with AEZS

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AEZS News
More AEZS News
InvestorsHub NewsWire

FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM

HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM

Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM

ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM

Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM

Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM

Start posting your company's news
Only $200 per official company press release!